Skip to main content
. 2019 Jan 5;10(2):342–349. doi: 10.1007/s13193-018-0860-5

Table 5.

The DFS and overall survival of patients with uterine sarcomas

DFS in months OS in months
Leiomyosarcoma 2.5 6.5
 1A (n-2) 26.5 34
 1B (n-4) 2.5 6.5
Endometrial stromal sarcoma 7 18
 1A (n-2) 5.5 18
 IVA (n-1) 144 200
 IVB (n-1) 4
Adenosarcoma 39 56
 1A (n-1) 39 56

One patient in stage 1A ESS was lost to follow up

OS overall survival, DFS disease-free survival